GitaThanarajasingamMD

PubMed

• 38 citations
  Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial.
  Amylou C. Dueck, Howard I. Scher, Antonia V. Bennett, Gina L. Mazza, Gita Thanarajasingam
  JAMA Oncology. 2020-02-13
• 18 citations
  Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials.
  Michael E Roth, Susan K Parsons, Patricia A Ganz, Lynne I Wagner, Pamela S Hinds
  Journal of the National Cancer Institute. 2023-01-10
• 78 citations
  Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop
  Paul G. Kluetz, Bindu Kanapuru, Steven Lemery, Laura Lee Johnson, Mallorie H. Fiero
  Value in Health. 2017-11-07

Abstracts/Posters

• A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
  Gita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life
  Gita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment Era
  Gita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Longitudinal toxicity analysis with novel summary metrics of lenalidomide maintenance in follicular lymphoma in ECOG-ACRIN 2408. 
  2019 ASCO Annual Meeting - 6/1/2019